Sorafine Cremogel
NDC Package 82160-368-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Sorafine Cremogel is serafine ® Cremogel is used as a moisturizing and nourishing Gel - Cream for oily and acne prone skin, it is recommended for dry and sensitive skin, eczema, flaky skin, and similar skin problems. Marketed by Pella Pharmaceuticals Co. Ltd, this product is identified by NDC 82160-368.

Identification & Billing

NDC Package Code
82160-368-01
Package Description
1 TUBE in 1 CARTON / 75 g in 1 TUBE
Product Code
82160-368
11-Digit Billing Format
82160036801

Clinical Specifications

Proprietary Name
Sorafine Cremogel
Dosage Form
-
Usage Information
Serafine ® Cremogel is used as a moisturizing and nourishing Gel - Cream for oily and acne prone skin, it is recommended for dry and sensitive skin, eczema, flaky skin, and similar skin problems. Serafine ® Cremogel prevents skin dryness and reduces roughness, relieves itching, gives a feeling of comfort and softness. Serafine ® Cremogel is distinguished by its non-fat composition, and contains jojoba oil which is suitable for oily skin, because of the similarity between its composition and the natural oils of the skin; which gives you a wonderful feeling of softness.

Regulatory & Marketing

Labeler Name
Pella Pharmaceuticals Co. Ltd
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
09-12-2011
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82160-368-01 identifies a specific commercial package of 1 tube in 1 carton / 75 g in 1 tube of Sorafine Cremogel, labeled by Pella Pharmaceuticals Co. Ltd. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pella Pharmaceuticals Co. Ltd on September 12, 2011. The current certification is valid through December 31, 2022.

How is this Pella Pharmaceuticals Co. Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82160036801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
82160-368-01
11-Digit CMS (5-4-2)
82160-0368-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.